07.01.2022 Symrise AG  DE000SYM9999

DGAP-News: Symrise accelerates international expansion in Pet Nutrition through acquisition of Schaffelaarbos


 

DGAP-News: Symrise AG / Key word(s): Acquisition/Expansion
Symrise accelerates international expansion in Pet Nutrition through acquisition of Schaffelaarbos

07.01.2022 / 08:29
The issuer is solely responsible for the content of this announcement.


  • Acquisition ideally complements Symrise's current pet food capabilities
  • Schaffelaarbos, a leading manufacturer of sustainable egg proteins
  • Ambition to become leading player in egg valorization, providing sustainable proteins to the pet food industry with a contribution to a positive circular food system
  • Closing expected January 2022


Symrise AG today announced that it has signed a purchase agreement for the acquisition of Schaffelaarbos, a dutch-based market leader for egg protein in pet food in the EU. With this transaction, Symrise will take a major strategic step in its accelerated global expansion in Pet Nutrition. By combining the activities of ADF/IsoNova in the USA with the state-of-the-art facility of Schaffelaarbos located in Barneveld, NL, Symrise will ideally complement its current capabilities. The annual sales of Schaffelaarbos amounts to around €25m. The closing of the transaction is expected in January 2022. The purchase amount has not been disclosed.

"The acquisition of Schaffelaarbos represents a prime opportunity to accelerate Symrise's ambition to become a reference global player in Pet nutritional solutions, while contributing to a positive circular food system. The combination of our activities of ADF/IsoNova in the USA and the leading position of Schaffelaarbos in the EU will enable us to even better serve our customers with a global portfolio and a regional supply chain - thereby further increasing customer intimacy. By bringing the two leading experts in the sector together, we will expand our product range in the area of high-quality protein from eggs, enhancing at the same time further our value proposition in Taste, Nutrition and Health", said Dr. Jean-Yves Parisot, President Flavor & Nutrition of Symrise AG.

In 2019, Symrise made its first step in Pet Nutrition with the acquisition of ADF/IsoNova, the reference provider of quality chicken protein and egg proteins for the US pet food industry, tapping into a new market segment. With the recent acquisition of Schaffelaarbos, Symrise is now further expanding its global presence and will take an immediate leading position in the European egg protein market, with long term access to high-quality raw materials and a customer base comprising leading pet food players. Schaffelaarbos ideally complements the existing capacities of Symrise in the USA. By combining the activities of the two recognized egg scrap valorization experts, Symrise intends to accelerate product innovation and break new ground for future growth and profitability.

Schaffelaarbos is a leading player in the manufacturing of sustainable egg proteins for the pet food industry in the EU. By processing eggs unsuitable for human consumption, Schaffelaarbos is the partner of choice across Europe. The company prevents unnecessary waste and contributes to a positive circular food system. Schaffelaarbos enjoys strong supplier intimacy with long term supply contracts. Employing 39 people, Schaffelaarbos has a fully automated, state-of-the-art facility in Barneveld, the Netherlands, as well as a facility under construction in Turkey with a strategic Joint Venture partner.

Mathieu Woltring, CEO of Schaffelaarbos, said: "I am very enthusiastic about this transaction. Our two organizations both value the industrial proximity to our clients and share a common vision based on the valorization of by-products. We will accelerate our journey together and join forces in making the pet food business even more sustainable in the future."

Symrise will acquire 100% of Schaffelaarbos from private investment firm Intersaction and the management. Symrise will finance the transaction through a dedicated bank facility.

About Schaffelaarbos:

Schaffelaarbos located in Barneveld (the Netherlands) produces circular proteins for the animal feed industry. By processing residual flows into high-quality protein sources and other ingredients Schaffelaarbos contributes to a circular food system preventing unnecessary waste. Its products ensure that valuable natural ingredients remain available and contribute to balanced feed with high-quality ingredients.Schaffelaarbos started more than thirty years ago with the processing of egg waste flows into high-quality protein sources for animal feed. In recent years, the range has expanded with the drying of yeast cell walls, a residual flow from the human food sector. The main drive of Schaffelaarbos is the constant search for alternative natural ingredients that contribute to making animal feed more sustainable. The company produces for the petfood-, young animal feed- and aquaculture markets.

About Symrise:

Symrise is a global supplier of fragrances, flavors, food, nutrition and cosmetic ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, pharmaceuticals and producers of nutritional supplements and pet food. Its sales of €3.5billion in the 2020 fiscal year make Symrise a leading global provider. Headquartered in Holzminden, Germany, the Group is represented by more than 100 locations in Europe, Africa, the Middle East, Asia, the United States and Latin America. Symrise works with its clients to develop new ideas and market-ready concepts for products that form an integral part of everyday life. Economic success and corporate responsibility are inextricably linked as part of this process. Symrise - always inspiring more .

www.symrise.com
 

Media Contact: Investor Contact:
Bernhard Kott Tobias Erfurth
Phone: +49 (0)5531 90-1721 Phone: +49 (0)5531 90-1879
Email: [email protected] Email: [email protected]
   
Social media:  
twitter.com/symriseag linkedin.com/company/symrise
youtube.com/agsymrise xing.com/companies/symrise
instagram.com/symriseag  
 

 

Financial calendar 2022

01 March - Full Year Results 2021
27 April - Interim Group Report January-March 2022
03 May - Annual General Meeting



07.01.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Symrise AG
Mühlenfeldstraße 1
37603 Holzminden
Germany
Phone: +49 (0)5531 90 0
E-mail: [email protected]
Internet: www.symrise.com
ISIN: DE000SYM9999, DE000SYM7787, DE000SYM7704
WKN: SYM999
Indices: DAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1265587

 
End of News DGAP News Service

1265587  07.01.2022 

fncls.ssp?fn=show_t_gif&application_id=1265587&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 2.996,29 3.154,03 3.407,85 3.520,45 3.825,69 4.618,48 4.730,19
EBITDA1,2 630,31 630,52 685,07 742,08 813,62 795,42 851,65
EBITDA-Marge3 21,04 19,99 20,10 21,08 21,27 17,22
EBIT1,4 431,59 433,97 455,35 487,51 558,96 503,98 559,36
EBIT-Marge5 14,40 13,76 13,36 13,85 14,61 10,91 11,83
Jahresüberschuss1 275,65 297,69 297,88 314,95 385,03 290,70 344,94
Netto-Marge6 9,20 9,44 8,74 8,95 10,06 6,29 7,29
Cashflow1,7 396,18 441,79 546,76 635,68 521,56 360,11 719,51
Ergebnis je Aktie8 2,06 2,08 2,12 2,22 2,70 2,00 2,44
Dividende8 0,88 0,90 0,95 0,97 1,02 1,10 0,85
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Ernst & Young

INVESTOR-INFORMATIONEN
©boersengefluester.de
Symrise
WKN Kurs in € Einschätzung Börsenwert in Mio. €
SYM999 105,200 Halten 14.704,02
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
30,94 38,44 0,81 46,99
KBV KCV KUV EV/EBITDA
4,23 20,44 3,11 20,40
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
1,10 1,10 1,05 15.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
25.04.2024 01.08.2024 24.10.2024 06.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
2,75% 7,81% 5,58% -2,50%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Symrise AG  ISIN: DE000SYM9999 können Sie bei EQS abrufen


Chemie , SYM999 , SY1 , XETR:SY1